Priming of human monocytes with PAF augments their production of tumor necrosis factor

M Rola-Pleszczynski1

  • 1Immunology Division, Faculty of Medicine, University of Sherbrooke, Que., Canada.

Journal of Lipid Mediators
|January 1, 1990
PubMed

Insights

Platelet-activating factor (PAF) primes human monocytes, significantly boosting their production of tumor necrosis factor (TNF) and interleukin-1 (IL-1). This priming enhances subsequent inflammatory and immune responses.

Area of Science:

  • Immunology
  • Cell Biology
  • Inflammation Research

Background:

  • Platelet-activating factor (PAF) is known to enhance cytokine production in monocytes.
  • Inflammatory mediators can act sequentially in vivo, necessitating studies on their temporal interactions.
  • Understanding monocyte priming is crucial for deciphering inflammatory and immune response dynamics.

Purpose of the Study:

  • To investigate the effect of PAF pre-exposure on human monocyte response to subsequent stimuli.
  • To determine how PAF priming influences tumor necrosis factor (TNF) production by monocytes.
  • To elucidate the role of PAF in augmenting monocyte activity in inflammatory contexts.

Main Methods:

  • Human monocytes were pre-exposed to varying concentrations of platelet-activating factor (PAF) for 18-48 hours.
  • Subsequent TNF production was measured in response to stimulation with muramyl dipeptide (MDP) and/or cytokines.
  • Comparative analysis of TNF production in primed versus unprimed monocytes.

Main Results:

  • Pre-exposure to PAF markedly enhanced subsequent TNF production by human monocytes.
  • This enhancement was observed in response to both MDP and MDP + cytokines stimulation.
  • The TNF production was increased by two- to three-fold following PAF priming.

Conclusions:

  • Priming human monocytes with PAF significantly augments their capacity for TNF production.
  • PAF-mediated priming appears to be a key mechanism in amplifying monocyte responses.
  • These findings suggest PAF plays an important role in modulating inflammatory and immune activities.